Announcing the 2019 HBA Board of Directors and Nominating Committee Leadership | HBA

Announcing the 2019 HBA Board of Directors and Nominating Committee Leadership

As the Healthcare Businesswomen's Association (HBA) works to close out a busy and successful 2018, we are proud to announce the leaders who will guide the organization in the new year.
 
The 2019 HBA board of directors and nominating committee were confirmed today at the HBA’s annual business meeting. 

2019 HBA Global Board of Directors 

Executive committee:

  • Chair: Rebecca Vermeulen, head, customer strategy and patient partnership, global medical affairs, Roche Pharmaceuticals 
  • Vice-chair: Simona King, finance executive, Bristol-Myers Squibb Company
  • Secretary/treasurer: Angela Gillespie, president, W2O wcg
  • President & CEO: Laurie Cooke RPH, HBA CEO (ex-officio non-voting)

Directors at large:

  • Erik D. Smith, PhD, principal, strategy & analytics, Deloitte Consulting
  • Jaime Marks Corvino, associate director, account management, KPMG LLP (non-voting)
  • Julie Ross, president, Advanced Clinical
  • Kim Fox, communications leader, office of the chief medical officer, Johnson & Johnson
  • La'Wana Harris, director, global leadership development, Sanofi US
  • Liz Paulson, strategic account executive, LexisNexis (chair, council of chapter presidents)
  • Ozge Saritosun Kurtoglu, VP, pricing strategy and insights, Pearson Corporation
  • Rita Ribeiro, head of marketing & communications, Publicis Health Solutions

2019 HBA Nominating Committee

  • Chair: Shannon Resetich, head of North America rare disease & rare blood disorders, Sanofi Genzyme
  • Joe DePinto, president, Cardinal Health Specialty Solutions
  • June Zeringue, consultant, Insigniam
  • Lisa George, chief human resources officer, Shearer’s Snacks
  • Quita Highsmith, head of alliance and advocacy relations, Genentech, Inc., A Member of the Roche Group

The incoming directors are inspired with their charge to continue the great work of the 2018 board, to champion the HBA’s mission to furthering the advancement and impact of women in the business of healthcare.

We are grateful and appreciative for the service of the 2018 HBA board of directors – those continuing their terms in 2019, and those committed advocates completing their terms this year. 

Thank you to the 2018 HBA board of directors:

Executive committee:

  • Chair: Shannon Resetich, head of North America rare disease & rare blood disorders, Sanofi Genzyme
  • Vice-chair: Rebecca Vermeulen, head, customer strategy and patient partnership, global medical affairs, Roche Pharmaceuticals 
  • Secretary/treasurer: Simona King, finance executive, Bristol-Myers Squibb Company
  • President & CEO: Laurie Cooke RPH, HBA CEO 

Directors at large:

  • Denice Pirrotti Hummel, JD, chief innovation officer, Lead Inclusively, Inc.
  • Joe DePinto, president, Cardinal Health Specialty Solutions
  • Julie Ross, president, Advanced Clinical
  • Kim Fox, communications leader, office of the chief medical officer, Johnson & Johnson
  • LeAnna Carey, global market strategy, Symplur (non-voting)
  • Liz Paulson, strategic account executive, LexisNexis (chair, council of chapter presidents)
  • Melissa Stahl, managing director, KPMG
  • Ozge Saritosun Kurtoglu, VP, pricing strategy and insights, Pearson Corporation

And a special thanks to the 2018 nominating committee for their support and hard work:

  • Chair: Rhonda Johnson, Market Performance Group 
  • Bejal Joshi, International Women in Science, Plush Communique Limited 
  • Jacopo Leonardi, ActivCore
  • Lisa George, Shearer’s Snacks
  • Quita Highsmith, Genentech, Inc., A Member of the Roche Group